 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.005.568 |
| Chemical and physical data | |
| Formula | C20H25NO3 |
| Molar mass | 327.424 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Benactyzine is ananticholinergicdrug that was used in the treatment ofclinical depression andanxiety disorders before it was pulled from the U.S. market by theFDA due to serious side effects.[2]
Its use for these indications was limited byside effects such asdry mouth andnausea, and at high doses it can cause more severe symptoms such asdeliriant andhallucinogenic effects.[2] "Large doses of benactyzine in normal subjects may produce a state resembling the action ofmescaline orLSD."[3]
Brand names have included:Suavitil,Phebex,Phobex,Cedad,Cevanol,Deprol,Lucidil,Morcain,Nutinal,Parasan. While there was some tentative evidence of effectiveness when combined withmeprobamate, with the medication no longer available it is not clinically important.[4]
Benactyzine was brought to market in the US in 1957 byMerck under the tradename, Suavitil.[5]
Media related toBenactyzine at Wikimedia Commons